• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins.中草药配方的再利用:分子对接和分子动力学模拟研究,以验证植物化合物对 SARS-CoV-2 蛋白的疗效。
J Biomol Struct Dyn. 2022 Nov;40(18):8405-8419. doi: 10.1080/07391102.2021.1922095. Epub 2021 May 14.
2
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
3
Binding and inhibitory effect of ravidasvir on 3CL of SARS-CoV-2: a molecular docking, molecular dynamics and MM/PBSA approach.雷迪帕韦对新型冠状病毒3CL的结合及抑制作用:分子对接、分子动力学和MM/PBSA方法
J Biomol Struct Dyn. 2022 Oct;40(16):7303-7310. doi: 10.1080/07391102.2021.1896388. Epub 2021 Mar 8.
4
Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.山油柑素和当药苦苷作为有前途的抑制 SARS-CoV-2 蛋白的候选物:一项计算研究。
J Biomol Struct Dyn. 2022 Jul;40(10):4532-4542. doi: 10.1080/07391102.2020.1860133. Epub 2020 Dec 11.
5
Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.基于结构的虚拟筛选、分子动力学和一些潜在植物化合物对 SARS-CoV-2 的结合亲和力计算。
J Biomol Struct Dyn. 2022 Sep;40(15):6921-6938. doi: 10.1080/07391102.2021.1891969. Epub 2021 Mar 8.
6
molecular docking, dynamics simulation and repurposing of some VEGFR-2 inhibitors based on the SARS-CoV-2-main-protease inhibitor N3.基于 SARS-CoV-2 主要蛋白酶抑制剂 N3 的一些 VEGFR-2 抑制剂的分子对接、动力学模拟和再利用。
J Biomol Struct Dyn. 2023 Nov;41(19):9267-9281. doi: 10.1080/07391102.2022.2148000. Epub 2022 Nov 18.
7
Molecular docking and simulation studies of natural compounds of L. against papain-like protease (PL) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world.基于分子对接和模拟研究,探讨了 L. 的天然化合物对 SARS CoV-2(冠状病毒)木瓜蛋白酶样蛋白酶(PL)的抑制作用,以期攻克当前世界范围内的大流行病局势。
J Biomol Struct Dyn. 2022 Aug;40(12):5665-5686. doi: 10.1080/07391102.2021.1873185. Epub 2021 Jan 18.
8
Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.靶向 SARS-CoV-2 主蛋白酶:基于结构的虚拟筛选、计算机 ADMET 研究和分子动力学模拟,以鉴定潜在的抑制剂。
J Biomol Struct Dyn. 2022 May;40(8):3609-3625. doi: 10.1080/07391102.2020.1848636. Epub 2020 Nov 23.
9
Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.通过分子对接、自由能计算和分子动力学研究鉴定一些新型嗪取代的 9-苯胺吖啶类化合物作为 COVID-19 的 SARS-CoV-2 抑制剂。
J Biomol Struct Dyn. 2021 Sep;39(15):5551-5562. doi: 10.1080/07391102.2020.1798285. Epub 2020 Jul 28.
10
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.合成类黄酮作为抗 SARS-CoV-2 主蛋白酶的潜在抗病毒药物。
J Biomol Struct Dyn. 2022 May;40(8):3777-3788. doi: 10.1080/07391102.2020.1850359. Epub 2020 Nov 30.

引用本文的文献

1
Pharmacoinformatics in identifying therapeutically important chemical species from Ayurvedic formulations employed in treating COVID-19 patients.药物信息学在从用于治疗新冠肺炎患者的阿育吠陀配方中识别具有治疗重要性的化学物质方面的应用。
J Ayurveda Integr Med. 2025 Jun 23;16(4):101161. doi: 10.1016/j.jaim.2025.101161.
2
Synthesizing network pharmacology, bioinformatics, and in vitro experimental verification to screen candidate targets of Salidroside for mitigating Alzheimer's disease.综合网络药理学、生物信息学和体外实验验证,以筛选红景天苷减轻阿尔茨海默病的候选靶点。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4539-4558. doi: 10.1007/s00210-024-03555-0. Epub 2024 Nov 6.
3
Daturataturin A Ameliorates Psoriasis by Regulating PPAR Pathway.滇乌头堿 A 通过调控 PPAR 通路改善银屑病。
Biochem Genet. 2024 Dec;62(6):4952-4966. doi: 10.1007/s10528-024-10680-1. Epub 2024 Feb 20.
4
Investigating small molecule compounds targeting psoriasis based on cMAP database and molecular dynamics simulation.基于 cMAP 数据库和分子动力学模拟探究靶向银屑病的小分子化合物。
Skin Res Technol. 2023 Apr;29(4):e13301. doi: 10.1111/srt.13301.
5
First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome.首个在印度西部人群中开展的全基因组关联研究报告揭示了宿主遗传因素对 COVID-19 严重程度和结局的影响。
Genomics. 2022 Jul;114(4):110399. doi: 10.1016/j.ygeno.2022.110399. Epub 2022 Jun 6.
6
Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.阿育吠陀草药预防和管理新冠肺炎患者的综述与评估中的机制见解
J Herb Med. 2022 Mar;32:100554. doi: 10.1016/j.hermed.2022.100554. Epub 2022 Feb 18.
7
Ayurvedic Response to COVID-19 Pandemic in Kerala, India and Its Impact on Quarantined Individuals - A Community Case Study.印度喀拉拉邦的阿育吠陀对 COVID-19 大流行的反应及其对隔离个体的影响-社区案例研究。
Front Public Health. 2021 Oct 15;9:732523. doi: 10.3389/fpubh.2021.732523. eCollection 2021.

本文引用的文献

1
High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA依赖性RNA聚合酶(RdRp)中瑞德西韦结合位点的高通量合理设计:对潜在耐药性的影响
iScience. 2020 Dec 26;24(1):101992. doi: 10.1016/j.isci.2020.101992. eCollection 2021 Jan 22.
2
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein.SARS-CoV-2 核衣壳磷酸蛋白识别 RNA 的结构基础。
PLoS Pathog. 2020 Dec 2;16(12):e1009100. doi: 10.1371/journal.ppat.1009100. eCollection 2020 Dec.
3
A consensus guideline of herbal medicine for coronavirus disease 2019.《2019冠状病毒病草药共识指南》
Integr Med Res. 2020 Sep;9(3):100470. doi: 10.1016/j.imr.2020.100470. Epub 2020 Jul 5.
4
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.SARS-CoV-2 全身炎症反应对洛匹那韦和羟氯喹血浆浓度的影响。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01177-20.
5
The need for COVID-19 research in low- and middle-income countries.在中低收入国家开展 COVID-19 研究的必要性。
Glob Health Res Policy. 2020 Jul 1;5:33. doi: 10.1186/s41256-020-00159-y. eCollection 2020.
6
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.免疫反应、炎症与 COVID-19 的临床谱。
Front Immunol. 2020 Jun 16;11:1441. doi: 10.3389/fimmu.2020.01441. eCollection 2020.
7
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.基于结构的 SARS-CoV-2 鸟嘌呤-N7 甲基转移酶(nsp14)的虚拟筛选和分子动力学模拟,以鉴定针对 COVID-19 的抗病毒抑制剂。
J Biomol Struct Dyn. 2021 Aug;39(13):4582-4593. doi: 10.1080/07391102.2020.1778535. Epub 2020 Jun 22.
8
Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.针对 SARS-CoV-2 刺突糖蛋白预融合构象:虚拟筛选和分子动力学模拟在识别潜在融合抑制剂中的应用。
Virus Res. 2020 Sep;286:198068. doi: 10.1016/j.virusres.2020.198068. Epub 2020 Jun 18.
9
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
10
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.针对抗SARS-CoV-2病毒化合物的分子对接与动力学模拟:一项计算研究。
Inform Med Unlocked. 2020;19:100345. doi: 10.1016/j.imu.2020.100345. Epub 2020 May 11.

中草药配方的再利用:分子对接和分子动力学模拟研究,以验证植物化合物对 SARS-CoV-2 蛋白的疗效。

Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins.

机构信息

Gujarat Biotechnology Research Centre, Gandhinagar, Gujarat, India.

Gujarat State Biotechnology Mission, Gandhinagar, Gujarat, India.

出版信息

J Biomol Struct Dyn. 2022 Nov;40(18):8405-8419. doi: 10.1080/07391102.2021.1922095. Epub 2021 May 14.

DOI:10.1080/07391102.2021.1922095
PMID:33988079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8127611/
Abstract

Herbal formulations mentioned in traditional medicinal texts were investigated for effect against SARS-COV-2 proteins involved in various functions of a virus such as attachment, entry, replication, transcription, etc. To repurpose and validate polyherbal formulations, molecular docking was performed to study the interactions of more than 150 compounds from various formulations against the SARS-CoV-2 proteins. Molecular dynamics (MD) simulation was performed to evaluate the interaction of top scored ligands with the various receptor proteins. The docking results showed that Liquiritic acid, Liquorice acid, Terchebulin, Glabrolide, Casuarinin, Corilagin, Chebulagic acid, Neochebulinic acid, Daturataturin A, and Taraxerol were effective against SARS-COV-2 proteins with higher binding affinities with different proteins. Results of MD simulations validated the stability of ligands from potent formulations with various receptors of SARS-CoV-2. Binding free energy analysis suggested the favourable interactions of phytocompounds with the recpetors. Besides, comparison of the various formulations determined that Pathyadi kwath, Sanjeevani vati, Yashtimadhu, Tribhuvan Keeratiras, and Septillin were more effective than Samshamni vati, AYUSH-64, and Trikatu. Polyherbal formulations having anti-COVID-19 potential can be used for the treatment with adequate monitoring. New formulations may also be developed for systematic trials based on ranking from these studies.Communicated by Ramaswamy H. Sarma.

摘要

对传统医学文献中提到的草药配方进行了研究,以考察其对 SARS-CoV-2 蛋白的作用,这些蛋白涉及病毒的各种功能,如附着、进入、复制、转录等。为了重新利用和验证复方草药制剂,进行了分子对接研究,以研究来自各种制剂的 150 多种化合物与 SARS-CoV-2 蛋白的相互作用。进行了分子动力学 (MD) 模拟,以评估得分最高的配体与各种受体蛋白的相互作用。对接结果表明,甘草酸、甘草酸、特彻布林、格拉布罗内酯、卡苏林、柯里拉京、没食子酸、新诃布酸、颠茄亭 A 和蒲公英醇对 SARS-CoV-2 蛋白有效,与不同蛋白的结合亲和力更高。MD 模拟结果验证了有效配方中的配体与 SARS-CoV-2 各种受体的稳定性。结合自由能分析表明,植物化合物与受体之间存在有利的相互作用。此外,对各种配方的比较确定,Pathyadi kwath、Sanjeevani vati、Yashtimadhu、Tribhuvan Keeratiras 和 Septillin 比 Samshamni vati、AYUSH-64 和 Trikatu 更有效。具有抗 COVID-19 潜力的复方草药制剂可在充分监测的情况下用于治疗。也可以根据这些研究的排名开发新的制剂进行系统试验。由 Ramaswamy H. Sarma 传达。